Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InCore is a medical technology company focused on developing innovative solutions for structural heart disease, specifically targeting mitral valve repair and replacement. The company's primary focus is on a transcatheter mitral valve repair system designed to treat patients with significant mitral regurgitation who are at high risk for traditional open-heart surgery. By utilizing a minimally invasive approach, InCore aims to provide a safer and more effective alternative for restoring valve function and improving patient outcomes. The company is currently advancing its lead technology through clinical evaluation to demonstrate safety and efficacy in human subjects.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on INCORE.